Last updated: June 18, 2018
Sponsor: Konkuk University Medical Center
Overall Status: Completed
Phase
N/A
Condition
Dementia
Osteoporosis
Treatment
N/AClinical Study ID
NCT02507609
KUH1160087
Ages > 50 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All adult (more than 50 years old) patients scheduled for total hip arthroplasty andtotal knee arthroplasty who have signed the written informed consent.
Exclusion
Exclusion Criteria:
Inability to give informed consent
Preexisting cognitive dysfunction or delirium
Known allergy to rocuronium sugammadex
Underlying liver dysfunction (AST and ALT more than 100 IU/l)
Underlying kidney dysfunction (Serum Creatinine more than 1.5 mg/dl)
Underlying neuromuscular disease
Patients taking any medication with potential interference with neuromusculartransmission
Study Design
Total Participants: 82
Study Start date:
September 08, 2015
Estimated Completion Date:
April 26, 2018
Study Description
Connect with a study center
Konkuk University Medical Center
Seoul, 143-729
Korea, Republic ofSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.